On September 19, 2025, Predictive Oncology Inc. stockholders approved a one-for-fifteen reverse stock split of common stock, effective September 29, 2025. Additionally, they approved the issuance of up to $10 million in common stock under a Standby Equity Purchase Agreement. Vote counts showed 3,739,479 in favor and 1,317,568 against the stock split proposal.